1. Home
  2. NTRA vs STZ Comparison

NTRA vs STZ Comparison

Compare NTRA & STZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTRA
  • STZ
  • Stock Information
  • Founded
  • NTRA 2003
  • STZ 1945
  • Country
  • NTRA United States
  • STZ United States
  • Employees
  • NTRA N/A
  • STZ N/A
  • Industry
  • NTRA Medical Specialities
  • STZ Beverages (Production/Distribution)
  • Sector
  • NTRA Health Care
  • STZ Consumer Staples
  • Exchange
  • NTRA Nasdaq
  • STZ Nasdaq
  • Market Cap
  • NTRA 24.9B
  • STZ 24.8B
  • IPO Year
  • NTRA 2015
  • STZ 1987
  • Fundamental
  • Price
  • NTRA $173.27
  • STZ $142.98
  • Analyst Decision
  • NTRA Strong Buy
  • STZ Buy
  • Analyst Count
  • NTRA 17
  • STZ 20
  • Target Price
  • NTRA $192.41
  • STZ $182.25
  • AVG Volume (30 Days)
  • NTRA 1.1M
  • STZ 3.3M
  • Earning Date
  • NTRA 11-11-2025
  • STZ 10-06-2025
  • Dividend Yield
  • NTRA N/A
  • STZ 2.86%
  • EPS Growth
  • NTRA N/A
  • STZ 116.66
  • EPS
  • NTRA N/A
  • STZ 6.84
  • Revenue
  • NTRA $1,964,250,000.00
  • STZ $9,624,000,000.00
  • Revenue This Year
  • NTRA $24.28
  • STZ N/A
  • Revenue Next Year
  • NTRA $15.22
  • STZ $0.91
  • P/E Ratio
  • NTRA N/A
  • STZ $20.86
  • Revenue Growth
  • NTRA 44.38
  • STZ N/A
  • 52 Week Low
  • NTRA $117.27
  • STZ $131.20
  • 52 Week High
  • NTRA $183.00
  • STZ $247.63
  • Technical
  • Relative Strength Index (RSI)
  • NTRA 59.76
  • STZ 51.57
  • Support Level
  • NTRA $157.43
  • STZ $138.00
  • Resistance Level
  • NTRA $173.62
  • STZ $147.60
  • Average True Range (ATR)
  • NTRA 5.35
  • STZ 3.43
  • MACD
  • NTRA 0.04
  • STZ 2.01
  • Stochastic Oscillator
  • NTRA 67.61
  • STZ 71.49

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

About STZ Constellation Brands Inc.

Constellation Brands is the largest provider of alcoholic beverages across the beer, wine, and spirits categories in the US, generating 84% of revenue from Mexican beer imports under top-selling brands such as Modelo and Corona. The rest of the business includes some remaining wine and spirits brands, categories where the company has pruned assets in recent years. With its exclusive rights tied to the Mexican beer brands effective only in the US, the firm has limited revenue exposure to international markets. Constellation owns a 26% stake in no-moat Canopy Growth, a medicinal and recreational cannabis producer in Canada, and has a 50/50 joint venture with glass manufacturer Owens-Illinois in Mexico.

Share on Social Networks: